{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/polycythaemia-erythrocytosis/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"09648da8-6172-59c1-aba9-f14b74a1e6a9","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 6ff10ea7-ce6b-4ab0-be3c-73f162076933 --><h2>When should I suspect polycythaemia/erythrocytosis?</h2><!-- end field 6ff10ea7-ce6b-4ab0-be3c-73f162076933 -->","summary":"","htmlStringContent":"<!-- begin item 968ee8f2-c52f-4105-b93c-3b5c2b23598a --><!-- begin field debe98c0-5b2d-49d3-baca-fe2ed3dd3fd7 --><ul><li><strong>Be aware that erythrocytosis may be found incidentally as a result of a full blood count (FBC) taken in a person who has not reported symptoms. </strong>The full blood count should be repeated after a minimum of one week to see whether the rise is transient. Previous results should also be rechecked to determine whether the trend was previously present. </li><li><strong>Suspect erythrocytosis in people experiencing symptoms potentially caused by hyperviscosity, including:</strong><ul><li>Chest and abdominal pain.</li><li>Myalgia and weakness.</li><li>Fatigue.</li><li>Headache — may be described as a sense of 'fullness' in the head and neck, with dizziness, and/or perspiration.</li><li>Tinnitus.</li><li>Blurred vision, temporary loss of vision in one or both eyes.</li><li>Paresthesia.</li><li>Slow mentation, sense of depersonalisation.</li></ul></li><li><strong>Additional symptoms that may indicate polycythaemia vera as the cause of erythrocytosis include:</strong><ul><li>Bruising.</li><li>Pruritis, especially on contact with warm water.</li><li>Abdominal discomfort (relating to splenomegaly).</li><li>Hyperhidrosis.</li><li>Tenderness or painful burning and/or redness of fingers, palms, heels, or toes.<ul><li><strong>Note:</strong> 10% to 15% of people with polycythaemia vera are diagnosed following an acute thrombotic event, and 2% to 8% following major haemorrhage.</li></ul></li></ul></li><li><strong>Take a full history:</strong><ul><li><strong>Ask about/note factors which may indicate polycythaemia vera, including:</strong><ul><li>Age over 40 years.</li><li>Personal history of haemorrhage, thrombosis, or Budd-Chiari syndrome.</li><li>Family history of polycythaemia vera.</li></ul></li><li><strong>Ask about/note factors which may indicate apparent erythrocytosis, including:</strong><ul><li>Obesity.</li><li>Smoking. </li><li>Alcohol excess.</li><li>Hypertension.</li><li>Use of thiazide diuretics, testosterone, or anabolic steroids.</li></ul></li><li><strong>Ask about/note factors which may underlie secondary erythrocytosis, such as:</strong><ul><li>Cardiac and respiratory symptoms or disease, smoking, potential exposure to carbon monoxide.</li><li>Excessive daytime sleepiness, snoring, sleep disturbances.</li><li>Previous renal transplantation.</li></ul></li></ul></li><li><strong>Perform an examination:</strong><ul><li>Note whether there is a ruddy complexion (indicative of erythrocytosis).</li><li>Examine the eyes to assess whether conjunctival plethora (indicative of erythrocytosis) is present.</li><li>Palpate the abdomen to elicit:<ul><li>Splenomegaly, which can be indicative of polycythaemia vera — however, bear in mind that a palpable spleen is present in only 40% of cases.</li><li>Abdominal masses. Benign and malignant uterine, renal, and hepatic tumours, which may be palpable, can secrete erythropoietin, leading to secondary erythrocytosis.</li></ul></li><li>Examine the digits, measure oxygen saturation, and listen to the chest — clubbing of digits, oxygen saturation <92% in room air, and/or abnormal heart or breath sounds may suggest secondary erythrocytosis caused by underlying cardiopulmonary disease.</li><li>Carry out urine dipstick analysis to identify possible renal causes of secondary erythrocytosis.</li></ul></li><li><strong>Consider <a class=\"topic-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/diagnosis/diagnosis/#differential-diagnosis\">differential diagnoses</a>.</strong></li><li><strong>Take blood samples</strong> <strong>(without a tourniquet if possible) for haemoglobin, mean corpuscular volume (MCV), haematocrit, white blood cell count (WBCs), platelet count, liver function tests (LFTs), urea and electrolytes and e-GFR.</strong><ul><li>Erythrocytosis is defined as haemoglobin >185 g/L and/or haematocrit (Hct) >0.52 in a male and haemoglobin >165 g/L an/or Hct >0.48 in a female.  A significant proportion of people with these findings will have apparent erythrocytosis. The results of these tests alongside clinical judgement (based on noted signs and symptoms and the presence/absence of risk factors for apparent erythrocytosis) should, therefore, be used to determine which people require immediate additional testing. As a guide:<ul><li>One-off values of Hct >0.6 (male); >0.56 (female) require additional investigations.</li><li>Polycythaemia vera is suggested by raised white blood cell and platelet counts in addition to high haematocrit. MCV is usually low in polycythaemia vera. LFTs are usually normal, but elevated values raise the possibility of Budd-Chiari syndrome. People exhibiting findings suggestive of polycythaemia vera should have further investigation. </li><li>Males with Hct >0.52, and females with Hct >0.48 with risk factors for apparent erythrocytosis, or signs and symptoms suggestive of secondary erythrocytosis, and without signs or symptoms suggestive of polycythaemia vera should be retested in two months following attempts to address apparent/secondary erythrocytosis. Repeat abnormal results should prompt additional investigations.</li><li>Secondary erythrocytosis may be suggested by abnormal LFTs, if there is a hepatic tumour. Abnormal renal function can indicate secondary erythrocytosis with an underlying renal cause.</li><li>Be aware that, in rare cases, a person (most commonly male) may present with 'masked' polycythaemia vera, where there is suggestive symptomatology or complications (such as unexplained thrombosis) but haemoglobin/haematocrit are clinically normal. In such cases, platelet counts are often elevated. Iron deficiency can also mask erythrocytosis — some cases of polycythaemia vera can therefore present with iron deficiency and a normal haemoglobin level.</li></ul></li></ul></li><li><strong>Additional investigations that may be carried out to confirm/refute a diagnosis include:</strong><ul><li>Serum erythropoietin — increased serum erythropoietin suggests secondary erythrocytosis, while decreased levels suggest polycythaemia vera, but normal levels do not rule out polycythaemia vera.</li><li>Serum ferritin — to screen for iron deficiency if a low MCV is found. Can support a diagnosis of polycythaemia vera in people with suggestive signs or symptoms but clinically normal haemoglobin.</li><li><em>JAK2</em> V617F mutation — positive finding is definitive for polycythaemia vera. Negative finding does not rule it out as around 5% of cases involve other mutations.</li><li>Serum uric acid (optional) — frequently elevated in polycythaemia vera.</li><li>Abdominal ultrasound — to detect splenomegaly (suggestive of polycythaemia vera) where physical examination is equivocal.</li></ul></li></ul><!-- end field debe98c0-5b2d-49d3-baca-fe2ed3dd3fd7 --><!-- end item 968ee8f2-c52f-4105-b93c-3b5c2b23598a -->","topic":{"id":"fa6be70e-4297-5c9a-b3cd-9583f15e3111","topicId":"fd54e0c5-4fe5-450d-9784-91b5e47c8754","topicName":"Polycythaemia/erythrocytosis","slug":"polycythaemia-erythrocytosis","lastRevised":"Last revised in September 2020","chapters":[{"id":"695f9a30-5f1b-5c8c-b771-0c9194a05dbe","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7dd62db3-3d83-5397-87de-2926d3fd4a22","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fe394ca3-8f2b-5b5b-97cf-db1e470cb964","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"63325ec1-5a65-517d-b0aa-d0e73bebbfca","slug":"changes","fullItemName":"Changes"},{"id":"d7d77004-b1a3-5b51-b127-56e529c85135","slug":"update","fullItemName":"Update"}]},{"id":"43b989c9-04a9-5339-b325-9131b5be941b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"dd6ff7fe-7c84-572b-8476-d38ff3f127b6","slug":"goals","fullItemName":"Goals"},{"id":"b5793099-ce5d-5936-b15e-74b920fb9648","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ff345f15-3d9a-5bde-8daf-a7935cbaf03a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f3fd1887-7475-5781-8fbf-fe5899828386","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e0f239a5-035b-518f-b47b-e9c2ba32eac2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37e2c554-6ed2-5a18-aaeb-04351cd1273a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d7d4ea60-5030-5464-990d-fa4317fe399e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8bd9e0dc-e10a-53f3-8c7b-9385de985b19","slug":"definition","fullItemName":"Definition"},{"id":"82d6faa0-d4d9-5b16-8749-a562fb4b9c4a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"492c4d23-53a9-5d43-ac41-bbf40de526d8","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"69cfa130-4762-5abc-9ddf-36ad93773d75","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"5c705230-ec55-58d0-83c7-3782f3fff5c0","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"09648da8-6172-59c1-aba9-f14b74a1e6a9","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"089b1374-e8b4-5137-a954-4b1f90ee4a45","fullItemName":"Management","slug":"management","subChapters":[{"id":"46e0c8f9-21ea-5ab6-a9ed-601bfd74f61c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"7cc68f5a-878e-564c-97aa-93d8d958e493","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"155ff0de-0d61-5d85-8d21-e9e9cee45889","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8c94b288-e2c4-56e8-8f74-a64ecc4a7198","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f2439e91-a3f2-5e18-a9d5-5e82382bce20","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"98ba96ac-671e-5fdc-bf1e-b66cf9498201","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"da8ecf5e-0c5a-5650-b332-70e4aba2d39b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6b7583d4-db4f-5b06-a69f-04a4f75b8cbb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c2217823-75aa-544d-ab7d-25d4d3f09c5c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5c705230-ec55-58d0-83c7-3782f3fff5c0","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"80107c9d-6ef0-57c5-bfe8-cbf171e18410","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":3,"htmlHeader":"<!-- begin field ea077ffe-2bab-442f-988a-a86a00aa3e44 --><h3>What else might it be?</h3><!-- end field ea077ffe-2bab-442f-988a-a86a00aa3e44 -->","summary":null,"htmlStringContent":"<!-- begin item ae9d3d5b-cd7f-4280-8c3a-a86a00aa3295 --><!-- begin field dfd8f422-e469-475b-bbb3-a86a00aa3e44 --><p><strong>The differential diagnoses of polycythaemia vera include:</strong></p><ul><li>Essential thrombocythaemia (ET) — can be difficult to distinguish clinically from polycythaemia vera. Splenomegaly is infrequent. A normal erythropoietin, isolated thrombocytosis, and absence of elevated haemoglobin concentration are suggestive of essential thrombocytosis.</li><li>Chronic myelogenous leukaemia (CML) — May be clinically indistinguishable from polycythaemia vera, although thrombosis is much less common with CML. Diagnosis is confirmed by screening for Philadelphia chromosome 9;22 translocation or its fusion protein product, BCR-ABL.</li></ul><!-- end field dfd8f422-e469-475b-bbb3-a86a00aa3e44 --><!-- end item ae9d3d5b-cd7f-4280-8c3a-a86a00aa3295 -->","subChapters":[]},{"id":"ccb5ab94-f5e1-568b-903c-4cc0d9287854","slug":"basis-for-recommendation-01c","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field fb30834e-db6b-4d4d-9297-c89068ed282d --><h3>Basis for recommendation</h3><!-- end field fb30834e-db6b-4d4d-9297-c89068ed282d -->","summary":null,"htmlStringContent":"<!-- begin item 01c036fe-70cc-46d8-9910-c4308ac014b8 --><!-- begin field 4b08864e-d092-4226-a622-086c2c07be65 --><p>The information on diagnosis of erythrocytosis and polycythaemia vera is based on expert opinion in the Oxfordshire Clinical Commissioning Group Referral Guidelines- <em>Polycythaemia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">Oxfordshire Clinical Commissioning Group, 2012</a>], the BMJ Best Practice guideline <em>Polycythaemia vera</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">BMJ Best pracrice, 2016</a>] and the British Medical Journal (BMJ) review article <em>The diagnosis and management of erythrocytosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">Keohane et al, 2013</a>].</p><h4>Interval for repeat blood tests </h4><ul><li>The recommendation that people with raised haematocrit with possible apparent erythrocytosis, or secondary erythrocytosis, and without signs or symptoms suggestive of polycythaemia vera should be retested within two months is based on expert opinion in the Oxfordshire Clinical Commissioning Group Referral Guidelines- <em>Polycythaemia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">Oxfordshire Clinical Commissioning Group, 2012</a>]. The advice in the BMJ Best Practice guideline <em>Polycythaemia vera</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">BMJ Best pracrice, 2016</a>] and the British Medical Journal  (BMJ) review article <em>The diagnosis and management of erythrocytosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">Keohane et al, 2013</a>] was broadly consistent with this, but did not specify an exact time interval for retesting, except for 'several weeks later' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycythaemia-erythrocytosis/references/\">BMJ Best pracrice, 2016</a>].</li></ul><p> </p><!-- end field 4b08864e-d092-4226-a622-086c2c07be65 --><!-- end item 01c036fe-70cc-46d8-9910-c4308ac014b8 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}